Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.360
+0.030 (0.69%)
At close: Jun 18, 2026, 4:00 PM EDT
4.280
-0.080 (-1.83%)
After-hours: Jun 18, 2026, 4:56 PM EDT
Atea Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
55
Market Cap
348.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 351.37M | 302.73M | 622.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 217.78M |
| Verastem | 49.59M |
| OmniAb | 28.94M |
| Opus Genetics | 11.98M |
| Upstream Bio | 3.32M |
| Compass Therapeutics | 850.00K |
AVIR News
- 1 day ago - Atea Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 23 days ago - Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026 - GlobeNewsWire
- 5 weeks ago - Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline - GlobeNewsWire
- 5 weeks ago - Atea Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Atea Pharmaceuticals Slides: Q1 2026 - Filings
- 5 weeks ago - Atea Pharmaceuticals Earnings release: Q1 2026 - Filings
- 5 weeks ago - Atea Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire